EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

NCT04664179 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

EBV-Related Hodgkin Lymphoma
EBV-Related Lymphoproliferative Disorder
EBV Related Non-Hodgkin's Lymphoma

Interventions

BIOLOGICAL: Dose Level 1A: 2 x 10^7 cells/m2
BIOLOGICAL: Dose Level 2A: 6 x 10^7 cells/m2
BIOLOGICAL: Dose Level 2B: 6 x 10^7 cells/m2
BIOLOGICAL: Dose Level 3B: 2 x 10^8 cells/m2
BIOLOGICAL: Dose Level 3A: 2 x 10^8 cells/m2

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]